| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | SVP, Research And Development
1 company
Glenn Gregory M is a President, R&D at NOVAVAX INC. Recent SEC Form 4 filings include 0 buys and 85 sells.
Estimated insider holdings value: $152K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 10,334 | $132.73 | $1,371,667.20 | -21.1% | -41.1% | -83.1% | |
| Oct 19, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 8,250 | $165.14 | $1,362,427.31 | -10.8% | -38.7% | -88.8% | |
| Oct 15, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 1,183 | $170.00 | $201,110.00 | -22.6% | -30.6% | -87.9% | |
| Oct 12, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 8,250 | $163.18 | $1,346,217.97 | -17.7% | -17.3% | -87.6% | |
| Oct 5, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 8,250 | $174.41 | $1,438,895.37 | -9.8% | -15.9% | -89.0% | |
| Sep 30, 2021 | NVAX Novavax Inc | President, R&D | Sell | 693 | $207.25 | $143,621.67 | -2.0% | -26.1% | -91.2% | |
| Sep 27, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 1,990 | $234.32 | $466,288.44 | -3.0% | -31.7% | -91.3% | |
| Sep 15, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 1,183 | $229.34 | $271,304.34 | -2.5% | -27.5% | -86.0% | |
| Aug 31, 2021 | NVAX Novavax Inc | President, R&D | Sell | 1,386 | $239.87 | $332,462.51 | -3.6% | -18.7% | -86.1% | |
| Aug 26, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 4,167 | $233.92 | $974,740.02 | -5.7% | -13.1% | -84.7% |